» Articles » PMID: 17211653

The Disruptive Effects of the CB1 Receptor Antagonist Rimonabant on Extinction Learning in Mice Are Task-specific

Overview
Specialty Pharmacology
Date 2007 Jan 11
PMID 17211653
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Disruption of CB(1) receptor signaling through the use of CB(1) (-/-) mice or the CB(1) receptor antagonist rimonabant (SR141716) has been demonstrated to impair extinction of learned responses in conditioned fear and Morris water maze tasks. In contrast, CB(1) (-/-) mice exhibited normal extinction rates in an appetitively motivated operant conditioning task.

Objectives: The purpose of this study was to test whether rimonabant would differentially disrupt extinction learning between fear-motivated and food-motivated tasks.

Materials And Methods: Separate groups of C57BL/6J mice were trained in two aversively motivated tasks, conditioned freezing and passive avoidance, and an appetitively motivated operant conditioning task at a fixed ratio (FR-5) schedule of food reinforcement. After acquisition, the respective reinforcers in each task were withheld, and an intraperitoneal injection of vehicle or rimonabant was given 30 min before each extinction session.

Results: Rimonabant (3 mg/kg) treatment significantly disrupted extinction in both the conditioned freezing and passive avoidance tasks but failed to affect extinction rates in the operant conditioning task, whether using daily or weekly extinction sessions. Interestingly, rimonabant (3 mg/kg) prevented the significant increases in lever pressing (i.e., extinction burst) that occurred during the first extinction session of the operant conditioning task.

Conclusions: These results support the hypothesis that the CB(1) receptor plays a vital role in the extinction of aversive memories but is not essential for extinction of learned responses in appetitively motivated tasks.

Citing Articles

The Role of Genetic Variations in the FAAH rs324420 Polymorphism and its Interaction with CRHR1 rs110402 and CNR1 rs2180619 in Anxiety and- Trauma Related Symptoms After Military Deployment.

Leen N, de Weijer A, Boks M, Baas J, Vermetten E, Geuze E Chronic Stress (Thousand Oaks). 2024; 8:24705470241285828.

PMID: 39484094 PMC: 11526235. DOI: 10.1177/24705470241285828.


A Theory of the Extinction Burst.

Shahan T Perspect Behav Sci. 2022; 45(3):495-519.

PMID: 36249175 PMC: 9458838. DOI: 10.1007/s40614-022-00340-3.


Basic and applied research on extinction bursts.

Fisher W, Greer B, Shahan T, Norris H J Appl Behav Anal. 2022; 56(1):4-28.

PMID: 36193974 PMC: 9868065. DOI: 10.1002/jaba.954.


The Role of the Endocannabinoids 2-AG and Anandamide in Clinical Symptoms and Treatment Outcome in Veterans with PTSD.

Leen N, de Weijer A, van Rooij S, Kennis M, Baas J, Geuze E Chronic Stress (Thousand Oaks). 2022; 6:24705470221107290.

PMID: 35707677 PMC: 9190205. DOI: 10.1177/24705470221107290.


The extinction burst: Impact of reinforcement time and level of analysis on measured prevalence.

Nist A, Shahan T J Exp Anal Behav. 2021; 116(2):131-148.

PMID: 34472626 PMC: 8482780. DOI: 10.1002/jeab.714.


References
1.
Winsauer P, Lambert P, Moerschbaecher J . Cannabinoid ligands and their effects on learning and performance in rhesus monkeys. Behav Pharmacol. 2000; 10(5):497-511. DOI: 10.1097/00008877-199909000-00008. View

2.
Kamprath K, Marsicano G, Tang J, Monory K, Bisogno T, Di Marzo V . Cannabinoid CB1 receptor mediates fear extinction via habituation-like processes. J Neurosci. 2006; 26(25):6677-86. PMC: 6673838. DOI: 10.1523/JNEUROSCI.0153-06.2006. View

3.
Hampson R, Deadwyler S . Cannabinoids reveal the necessity of hippocampal neural encoding for short-term memory in rats. J Neurosci. 2000; 20(23):8932-42. PMC: 6773063. View

4.
Freedland C, Poston J, Porrino L . Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding. Pharmacol Biochem Behav. 2000; 67(2):265-70. DOI: 10.1016/s0091-3057(00)00359-2. View

5.
Sim-Selley L, Brunk L, Selley D . Inhibitory effects of SR141716A on G-protein activation in rat brain. Eur J Pharmacol. 2001; 414(2-3):135-43. DOI: 10.1016/s0014-2999(01)00784-1. View